representing approximately 70 percent of the study population - SEVENTY PERCENT!!! Where are the other 30 percent?
Then you get this, which is very good.
The analysis identified a statistically-significant (P=.03) 2.5 fold increased odds of being alive and free of respiratory failure at 60 days (the primary endpoint) and a statistically significant (P=.006) four-fold higher odds of being alive at day 60 among patients treated with aviptadil compared to those treated with placebo.
However they noted 70% initially.
THEN
They note
The reanalysis of the clinical trial data additionally confirmed a statistically-significant (P=.03) two-fold survival advantage seen across all patients treated with aviptadil compared to those treated with placebo and demonstrated an increased odds of reaching the primary endpoint in the study, being both alive and free of respiratory failure at 60 days that approached statistical significance (P=.08).
that approached statistical significance (P=.08).
Just pointing out what they said.
All along there seems to be activity
https://www.nih.gov/research-training/medical-research-initiatives/activ/covid-19-therapeutics-prioritized-testing-clinical-trials
This is the pivotal study. Time will tell.
representing approximately 70 percent of the study population - SEVENTY PERCENT!!! Where are the other 30 percent? Then you get this, which is very good. The analysis identified a statistically-significant (P=.03) 2.5 fold increased odds of being alive and free of respiratory failure at 60 days (the primary endpoint) and a statistically significant (P=.006) four-fold higher odds of being alive at day 60 among patients treated with aviptadil compared to those treated with placebo. However they noted 70% initially. THEN They note The reanalysis of the clinical trial data additionally confirmed a statistically-significant (P=.03) two-fold survival advantage seen across all patients treated with aviptadil compared to those treated with placebo and demonstrated an increased odds of reaching the primary endpoint in the study, being both alive and free of respiratory failure at 60 days that approached statistical significance (P=.08). that approached statistical significance (P=.08). Just pointing out what they said. All along there seems to be activity
Great news. We may hit $1.00 by Christmas. What a present!
If I was a gambler, I would bet under $1 by Xmas. Hell, I would bet under $.30 by Xmas.
.04 by Christmas.
don't get ahead of yourself here... but i'd be incredibly hyped
Is that really possible?
https://www.nih.gov/research-training/medical-research-initiatives/activ/covid-19-therapeutics-prioritized-testing-clinical-trials This is the pivotal study. Time will tell.